"High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer

Summary We report the results of a long‐term (12.8 Years) follow‐up study of the detection of malignnat and benign skin tumours in patients with psoriasis, who were treated with PUVA according to the European, ‘high sinle‐dose’ regimen. A total of 13 squamous cell carcinomas (SCC) and 24 basal cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 1991-01, Vol.124 (1), p.49-55
Hauptverfasser: BRUYNZEEL, I., BERGMAN, W., HARTEVELT, H.M., KENTER, C.C.A., VAN DE VELDE, E.A., SCHOTHORST, A.A., SUURMOND, D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 55
container_issue 1
container_start_page 49
container_title British journal of dermatology (1951)
container_volume 124
creator BRUYNZEEL, I.
BERGMAN, W.
HARTEVELT, H.M.
KENTER, C.C.A.
VAN DE VELDE, E.A.
SCHOTHORST, A.A.
SUURMOND, D.
description Summary We report the results of a long‐term (12.8 Years) follow‐up study of the detection of malignnat and benign skin tumours in patients with psoriasis, who were treated with PUVA according to the European, ‘high sinle‐dose’ regimen. A total of 13 squamous cell carcinomas (SCC) and 24 basal cell carcinomas (BCC) were diagnosed in 11 of 260 patients. The incidence of both SCC and BCC was increased in comparison with the general Dutch population. The ratio of SCC to BCC in the general population was 1:8 but was 1:2:5 in our study group. A positive correlation was observed between the development of SCC and the total UVA dosege, the age of the patient at the start of the PUVA treatment and a history of arsenic use. This dose‐realted increase in the incidence of SCC, reported in studies from the U.S.A., has not been found in earlier European studies. The average time period between the start of PUVA therapy and the diagnosis of the first malignant skin tumour was 6.0 years for SCC and 4.7 years for BCC. Among the 49 benign skin tumours were actinic keratoses, a kerato‐acanthoma and ‘PUVA keratoses’, a newly described hyperkeratotic lesion, especially found in PUVA‐treated patients.
doi_str_mv 10.1111/j.1365-2133.1991.tb03281.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16084471</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16084471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3829-9c678816b14da4d47c9f462f0fe360c8a5df3573c83ccc06562f1d49c3d49fef3</originalsourceid><addsrcrecordid>eNqVkM1u1DAUhS0EKkPLIyBZlYBVgh3_JEHqorSlQ1vxJwoSG8vjXA-eJvHUnojp2-Moo7ZbvLAX53z29YfQISU5TevdKqdMiqygjOW0rmm-WRBWVDTfPkGz--gpmhFCyozUkj1HL2JcEUIZEWQP7SWKUS5m6Pfh3C3_4Oj6ZQtZ4yO8xWdD8GvQPf56_fMYB1i6Dnqs2-ix0UOEiFMGWwMxYm9x7_usg1b3vtM43rg-tXoD4QA9swmCl7tzH11_PPtxMs-uvpx_Ojm-ygyrijqrjSyrisoF5Y3mDS9NbbksLLHAJDGVFo1lomSmYsYYIkXKaMNrw9JmwbJ99Ga6dx387QBxozoXDbRpIvBDVFSSivOSpuL7qWiCjzGAVevgOh3uFCVqFKtWarSnRntqFKt2YtU2wa92rwyLDpoHdDKZ8te7XEejWxuSAxcf1dKfhBiHOJp6f10Ld_8xgfpwccrrxGcT7-IGtve8DjdKlqwU6tfnc3XJv5HL4rtQc_YPSOajHA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16084471</pqid></control><display><type>article</type><title>"High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>BRUYNZEEL, I. ; BERGMAN, W. ; HARTEVELT, H.M. ; KENTER, C.C.A. ; VAN DE VELDE, E.A. ; SCHOTHORST, A.A. ; SUURMOND, D.</creator><creatorcontrib>BRUYNZEEL, I. ; BERGMAN, W. ; HARTEVELT, H.M. ; KENTER, C.C.A. ; VAN DE VELDE, E.A. ; SCHOTHORST, A.A. ; SUURMOND, D.</creatorcontrib><description>Summary We report the results of a long‐term (12.8 Years) follow‐up study of the detection of malignnat and benign skin tumours in patients with psoriasis, who were treated with PUVA according to the European, ‘high sinle‐dose’ regimen. A total of 13 squamous cell carcinomas (SCC) and 24 basal cell carcinomas (BCC) were diagnosed in 11 of 260 patients. The incidence of both SCC and BCC was increased in comparison with the general Dutch population. The ratio of SCC to BCC in the general population was 1:8 but was 1:2:5 in our study group. A positive correlation was observed between the development of SCC and the total UVA dosege, the age of the patient at the start of the PUVA treatment and a history of arsenic use. This dose‐realted increase in the incidence of SCC, reported in studies from the U.S.A., has not been found in earlier European studies. The average time period between the start of PUVA therapy and the diagnosis of the first malignant skin tumour was 6.0 years for SCC and 4.7 years for BCC. Among the 49 benign skin tumours were actinic keratoses, a kerato‐acanthoma and ‘PUVA keratoses’, a newly described hyperkeratotic lesion, especially found in PUVA‐treated patients.</description><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/j.1365-2133.1991.tb03281.x</identifier><identifier>PMID: 1993145</identifier><identifier>CODEN: BJDEAZ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Age Factors ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Carcinoma, Basal Cell - chemically induced ; Carcinoma, Basal Cell - epidemiology ; Carcinoma, Squamous Cell - chemically induced ; Carcinoma, Squamous Cell - epidemiology ; Diseases of the skin. Cosmetics ; Female ; Follow-Up Studies ; Humans ; Incidence ; Keratoacanthoma - chemically induced ; Keratoacanthoma - pathology ; Male ; Medical sciences ; Middle Aged ; Psoriasis - drug therapy ; PUVA Therapy - adverse effects ; PUVA Therapy - methods ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Skin - pathology ; Skin Neoplasms - chemically induced ; Skin Neoplasms - epidemiology</subject><ispartof>British journal of dermatology (1951), 1991-01, Vol.124 (1), p.49-55</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3829-9c678816b14da4d47c9f462f0fe360c8a5df3573c83ccc06562f1d49c3d49fef3</citedby><cites>FETCH-LOGICAL-c3829-9c678816b14da4d47c9f462f0fe360c8a5df3573c83ccc06562f1d49c3d49fef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2133.1991.tb03281.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2133.1991.tb03281.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,4024,27923,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19462551$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1993145$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BRUYNZEEL, I.</creatorcontrib><creatorcontrib>BERGMAN, W.</creatorcontrib><creatorcontrib>HARTEVELT, H.M.</creatorcontrib><creatorcontrib>KENTER, C.C.A.</creatorcontrib><creatorcontrib>VAN DE VELDE, E.A.</creatorcontrib><creatorcontrib>SCHOTHORST, A.A.</creatorcontrib><creatorcontrib>SUURMOND, D.</creatorcontrib><title>"High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><description>Summary We report the results of a long‐term (12.8 Years) follow‐up study of the detection of malignnat and benign skin tumours in patients with psoriasis, who were treated with PUVA according to the European, ‘high sinle‐dose’ regimen. A total of 13 squamous cell carcinomas (SCC) and 24 basal cell carcinomas (BCC) were diagnosed in 11 of 260 patients. The incidence of both SCC and BCC was increased in comparison with the general Dutch population. The ratio of SCC to BCC in the general population was 1:8 but was 1:2:5 in our study group. A positive correlation was observed between the development of SCC and the total UVA dosege, the age of the patient at the start of the PUVA treatment and a history of arsenic use. This dose‐realted increase in the incidence of SCC, reported in studies from the U.S.A., has not been found in earlier European studies. The average time period between the start of PUVA therapy and the diagnosis of the first malignant skin tumour was 6.0 years for SCC and 4.7 years for BCC. Among the 49 benign skin tumours were actinic keratoses, a kerato‐acanthoma and ‘PUVA keratoses’, a newly described hyperkeratotic lesion, especially found in PUVA‐treated patients.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Basal Cell - chemically induced</subject><subject>Carcinoma, Basal Cell - epidemiology</subject><subject>Carcinoma, Squamous Cell - chemically induced</subject><subject>Carcinoma, Squamous Cell - epidemiology</subject><subject>Diseases of the skin. Cosmetics</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Incidence</subject><subject>Keratoacanthoma - chemically induced</subject><subject>Keratoacanthoma - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Psoriasis - drug therapy</subject><subject>PUVA Therapy - adverse effects</subject><subject>PUVA Therapy - methods</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Skin - pathology</subject><subject>Skin Neoplasms - chemically induced</subject><subject>Skin Neoplasms - epidemiology</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkM1u1DAUhS0EKkPLIyBZlYBVgh3_JEHqorSlQ1vxJwoSG8vjXA-eJvHUnojp2-Moo7ZbvLAX53z29YfQISU5TevdKqdMiqygjOW0rmm-WRBWVDTfPkGz--gpmhFCyozUkj1HL2JcEUIZEWQP7SWKUS5m6Pfh3C3_4Oj6ZQtZ4yO8xWdD8GvQPf56_fMYB1i6Dnqs2-ix0UOEiFMGWwMxYm9x7_usg1b3vtM43rg-tXoD4QA9swmCl7tzH11_PPtxMs-uvpx_Ojm-ygyrijqrjSyrisoF5Y3mDS9NbbksLLHAJDGVFo1lomSmYsYYIkXKaMNrw9JmwbJ99Ga6dx387QBxozoXDbRpIvBDVFSSivOSpuL7qWiCjzGAVevgOh3uFCVqFKtWarSnRntqFKt2YtU2wa92rwyLDpoHdDKZ8te7XEejWxuSAxcf1dKfhBiHOJp6f10Ld_8xgfpwccrrxGcT7-IGtve8DjdKlqwU6tfnc3XJv5HL4rtQc_YPSOajHA</recordid><startdate>199101</startdate><enddate>199101</enddate><creator>BRUYNZEEL, I.</creator><creator>BERGMAN, W.</creator><creator>HARTEVELT, H.M.</creator><creator>KENTER, C.C.A.</creator><creator>VAN DE VELDE, E.A.</creator><creator>SCHOTHORST, A.A.</creator><creator>SUURMOND, D.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>199101</creationdate><title>"High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer</title><author>BRUYNZEEL, I. ; BERGMAN, W. ; HARTEVELT, H.M. ; KENTER, C.C.A. ; VAN DE VELDE, E.A. ; SCHOTHORST, A.A. ; SUURMOND, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3829-9c678816b14da4d47c9f462f0fe360c8a5df3573c83ccc06562f1d49c3d49fef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Basal Cell - chemically induced</topic><topic>Carcinoma, Basal Cell - epidemiology</topic><topic>Carcinoma, Squamous Cell - chemically induced</topic><topic>Carcinoma, Squamous Cell - epidemiology</topic><topic>Diseases of the skin. Cosmetics</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Incidence</topic><topic>Keratoacanthoma - chemically induced</topic><topic>Keratoacanthoma - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Psoriasis - drug therapy</topic><topic>PUVA Therapy - adverse effects</topic><topic>PUVA Therapy - methods</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Skin - pathology</topic><topic>Skin Neoplasms - chemically induced</topic><topic>Skin Neoplasms - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BRUYNZEEL, I.</creatorcontrib><creatorcontrib>BERGMAN, W.</creatorcontrib><creatorcontrib>HARTEVELT, H.M.</creatorcontrib><creatorcontrib>KENTER, C.C.A.</creatorcontrib><creatorcontrib>VAN DE VELDE, E.A.</creatorcontrib><creatorcontrib>SCHOTHORST, A.A.</creatorcontrib><creatorcontrib>SUURMOND, D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BRUYNZEEL, I.</au><au>BERGMAN, W.</au><au>HARTEVELT, H.M.</au><au>KENTER, C.C.A.</au><au>VAN DE VELDE, E.A.</au><au>SCHOTHORST, A.A.</au><au>SUURMOND, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>"High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>1991-01</date><risdate>1991</risdate><volume>124</volume><issue>1</issue><spage>49</spage><epage>55</epage><pages>49-55</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><coden>BJDEAZ</coden><abstract>Summary We report the results of a long‐term (12.8 Years) follow‐up study of the detection of malignnat and benign skin tumours in patients with psoriasis, who were treated with PUVA according to the European, ‘high sinle‐dose’ regimen. A total of 13 squamous cell carcinomas (SCC) and 24 basal cell carcinomas (BCC) were diagnosed in 11 of 260 patients. The incidence of both SCC and BCC was increased in comparison with the general Dutch population. The ratio of SCC to BCC in the general population was 1:8 but was 1:2:5 in our study group. A positive correlation was observed between the development of SCC and the total UVA dosege, the age of the patient at the start of the PUVA treatment and a history of arsenic use. This dose‐realted increase in the incidence of SCC, reported in studies from the U.S.A., has not been found in earlier European studies. The average time period between the start of PUVA therapy and the diagnosis of the first malignant skin tumour was 6.0 years for SCC and 4.7 years for BCC. Among the 49 benign skin tumours were actinic keratoses, a kerato‐acanthoma and ‘PUVA keratoses’, a newly described hyperkeratotic lesion, especially found in PUVA‐treated patients.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>1993145</pmid><doi>10.1111/j.1365-2133.1991.tb03281.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-0963
ispartof British journal of dermatology (1951), 1991-01, Vol.124 (1), p.49-55
issn 0007-0963
1365-2133
language eng
recordid cdi_proquest_miscellaneous_16084471
source MEDLINE; Wiley Online Library All Journals
subjects Age Factors
Aged
Aged, 80 and over
Biological and medical sciences
Carcinoma, Basal Cell - chemically induced
Carcinoma, Basal Cell - epidemiology
Carcinoma, Squamous Cell - chemically induced
Carcinoma, Squamous Cell - epidemiology
Diseases of the skin. Cosmetics
Female
Follow-Up Studies
Humans
Incidence
Keratoacanthoma - chemically induced
Keratoacanthoma - pathology
Male
Medical sciences
Middle Aged
Psoriasis - drug therapy
PUVA Therapy - adverse effects
PUVA Therapy - methods
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Skin - pathology
Skin Neoplasms - chemically induced
Skin Neoplasms - epidemiology
title "High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T18%3A33%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%22High%20single-dose'%20European%20PUVA%20regimen%20also%20causes%20an%20excess%20of%20non-melanoma%20skin%20cancer&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=BRUYNZEEL,%20I.&rft.date=1991-01&rft.volume=124&rft.issue=1&rft.spage=49&rft.epage=55&rft.pages=49-55&rft.issn=0007-0963&rft.eissn=1365-2133&rft.coden=BJDEAZ&rft_id=info:doi/10.1111/j.1365-2133.1991.tb03281.x&rft_dat=%3Cproquest_cross%3E16084471%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16084471&rft_id=info:pmid/1993145&rfr_iscdi=true